Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Immune cells capable of clearing latent infections in vivo, preparation method and application thereof

A technology of immune cells and cells, applied in the application field of preparations

Active Publication Date: 2020-08-25
赛德特生物制药有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Since this type of cell expresses both CD3+ and CD56+ membrane protein molecules, it is also called NK cell-like T lymphocyte, which has both the strong anti-tumor activity of T lymphocytes and the non-MHC-restricted tumor killing advantages of NK cells. However, this method still has limitations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immune cells capable of clearing latent infections in vivo, preparation method and application thereof
  • Immune cells capable of clearing latent infections in vivo, preparation method and application thereof
  • Immune cells capable of clearing latent infections in vivo, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Embodiment 1. Preparation of SIET cells

[0058] 1. Isolation of Peripheral Blood Lymphocytes

[0059] (1) One blood draw volume: 150ml, anticoagulated with heparin. 150ml of whole blood can normally get 1.5-2×10 8 cells, can plant a 75cm 2 Culture flask; the peripheral blood treated with heparin anticoagulation was divided into centrifuge tubes, centrifuged at 1800rpm for 15min, and the supernatant was discarded;

[0060] (2) Dilute the blood: AIMV culture medium is used to dilute the blood to make a lymphocyte suspension;

[0061] (3) 25ml of lymphocyte suspension was carefully placed on 12.5ml of lymphocyte separation medium, centrifuged at 1800rpm for 15min, and the lifting speed was adjusted to the lowest;

[0062] (4) Take the upper part of the plasma and keep it in a refrigerator at 4°C;

[0063] (5) Take the lymphocyte layer, place it in a 50ml centrifuge tube, add AIMV medium to a total volume of 50ml, centrifuge at 1800rpm for 5min;

[0064] (6) Discard ...

Embodiment 2

[0101] Example 2.Detection of SIET cell expansion ability

[0102] Adopt the method for embodiment 1 to cultivate, and take the SIET cells that culture time is the 0th, 3, 5, 7, 9, 12 days, detect cell proliferation situation, as figure 1 . Depend on figure 1 It can be seen that the proliferation of SIET cells cultured by the method of the present invention is better.

Embodiment 3

[0103] Example 3.SIET cell viability detection

[0104] The method of Example 1 was used to culture, and 100 μl of cells cultured for 12 days was taken, and 100 μl of 0.4% trypan blue staining solution was added. The living cells were not stained, and the dead cells were stained blue. The results are shown in Table 1.

[0105] Table 1

[0106] sample 1 sample 2 sample 3 Percentage of Viable Cells 95.5％ 97.1％ 95.9％

[0107] It can be seen from Table 1 that the viability of the cells prepared by the present invention is greater than 95%, and the viability of the cultured SIET cells is better.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an immune cell capable of removing recessive infection in vivo, and a preparation method and application thereof. The preparation method of the immune cells comprises the stepsthat peripheral blood mononuclear cells are separated and purified in vitro; and the peripheral blood mononuclear cells are activated by using a cell activator I; wherein the cell activator I comprises IL-2, IFN-gamma, GM-CSF, IL-4 and TNF-alpha, and is configured in normal saline; the activated cells are amplified with a cell activator II; the cell activator II comprises IL-2, IFN-gamma and IL-15, and is configured in normal saline; and the immune cells are harvested. According to the immune cell capable of removing the recessive infection in vivo, the immune can be amplified and returned tothe human body by using immune cells against bacteria, fungi, viruses, Chlamydia and Barton's small in vitro source factors, the purpose of reducing infection and eliminating hidden infection is achieved, disease occurrence is reduced, and aging is delayed.

Description

technical field [0001] The present invention relates to an immune cell capable of eliminating latent infection in the body and its preparation method and application, in particular, to an immune cell SIET (Silent Infection Elimination T cells) prepared by activating and expanding peripheral blood mononuclear cells ) and its preparation method, as well as its application in the preparation of preparations for reducing infection and clearing occult infection, belong to the field of biotechnology. Background technique [0002] Recessive infection is also called subclinical infection. It means that after the pathogen invades the human body, it only causes the body to produce a specific immune response, causing no or only slight tissue damage, so it does not show any clinical symptoms, signs, or even biochemical changes, and can only be detected by immunological examination. Find. [0003] Among them, the factors of cancer infection mainly include: hepatitis B virus (Hepatitis ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/0783C12N5/078A61K35/17A61P31/04A61P31/10A61P31/12A61P39/06
CPCA61K35/17A61P31/04A61P31/10A61P31/12A61P39/06C12N5/0634C12N5/0636C12N2501/22C12N2501/2302C12N2501/2304C12N2501/2315C12N2501/24C12N2501/25
Inventor 古松海吴茂友蔡晓晴康国媛
Owner 赛德特生物制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com